Cooper Companies | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 13.44B 435M 2025-06
Align Technology USD 1.99B 47.08M 2025-03
AtriCure USD 68.84M 7.62M 2025-06
Avanos Medical USD 137.2M 28.7M 2025-03
Bausch Health Companies USD 4.26B 2.5B 2025-03
Baxter International USD 3.48B 3.03B 2025-03
Bayer EUR 27.96B 993M 2025-03
Becton, Dickinson and Co. USD 7.69B 27M 2025-03
Boston Scientific USD 5.06B 1.34B 2025-03
Cooper Companies USD 1.01B 12.9M 2025-04
Dentsply International USD 1.79B 204M 2025-03
Dexcom USD 3.31B 271.6M 2025-06
Edwards Lifesciences USD 1.39B 110.4M 2025-03
Globus Medical USD 384.7M 471.21M 2025-03
Haemonetics USD 253.23M 20.71M 2024-12
Hologic USD 962.5M 27.2M 2025-06
Insulet USD 520.4M 8M 2025-03
Integra LifeSciences USD 929.81M 11.35M 2025-06
Intuitive Surgical USD 2.21B 197.4M 2025-06
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 12.88B 1.04B 2025-04
Merit Medical Systems USD 225.57M 28.75M 2025-06
Novartis USD 28.69B 560M 2024-12
ResMed USD 940.52M 88.56M 2025-03
STAAR Surgical USD 68.36M 1.95M 2025-03
Steris USD 1.02B 131.05M 2025-03
Stryker USD 7.93B 313M 2025-03
Tandem Diabetes Care USD 288.18M 41.13M 2025-03
Teleflex USD 675.91M 26.55M 2025-03
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12


Cooper Companies Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.